Related Experiment Video
Updated: Feb 2, 2026

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells
Published on: March 8, 2019
Contribution of microRNAs to the immunosuppressive function of mesenchymal stem cells
Yves-Marie Pers1, Marie Maumus2, Claire Bony2
1IRMB, University Montpellier, INSERM, CHU Montpellier, Montpellier, France; Clinical Immunology and Osteoarticular Diseases Therapeutic Unit, Lapeyronie University Hospital, Montpellier, France.
Abstract:
Mesenchymal stem/stromal cells (MSCs) are progenitor cells identified in many adult tissues, in particular in bone marrow or adipose tissue and, in placental tissues. MSCs exert pleiotropic functions that render them attractive for many clinical applications, both in degenerative and inflammatory diseases. Their main mode of action is through the secretion of trophic factors that can be released in the extracellular milieu or packaged within extracellular vesicles. These factors can be proteins, lipids, mRNAs or miRNAs that possess diverse effects, notably pro-angiogenic, anti-fibrotic, anti-apoptotic or anti-inflammatory. The anti-inflammatory role of a number of miRNAs has been demonstrated with different types of immune cells but few have been associated with the immunomodulatory function of MSCs. In this review, we summarize the data on the miRNAs that have been validated as participating to the anti-inflammatory role of MSCs.
Insights
Mesenchymal stem/stromal cells (MSCs) use microRNAs (miRNAs) to reduce inflammation. This review highlights validated miRNAs involved in MSCs' anti-inflammatory effects for potential therapeutic applications.
Area of Science:
- Regenerative Medicine
- Immunology
- Molecular Biology
Background:
- Mesenchymal stem/stromal cells (MSCs) are progenitor cells found in various adult and placental tissues.
- MSCs possess pleiotropic functions, making them promising for treating degenerative and inflammatory diseases.
- Their therapeutic effects are primarily mediated by secreted trophic factors, including extracellular vesicles containing proteins, lipids, mRNAs, and miRNAs.
Purpose of the Study:
- To review and summarize the current data on microRNAs (miRNAs) that have been validated as key contributors to the anti-inflammatory function of MSCs.
- To highlight the specific miRNAs involved in MSC-mediated immunomodulation.
- To provide insights into the therapeutic potential of MSC-derived miRNAs in inflammatory conditions.
Main Methods:
- Literature review of scientific publications.
- Analysis of studies validating the role of specific miRNAs in MSC immunomodulatory functions.
- Synthesis of data on miRNA mechanisms and effects on immune cells.
Main Results:
- Several miRNAs have been identified and validated for their role in the anti-inflammatory capacity of MSCs.
- These miRNAs contribute to MSCs' immunomodulatory effects through various mechanisms.
- The specific anti-inflammatory actions of these miRNAs are detailed, offering a molecular basis for MSC therapies.
Conclusions:
- MicroRNAs are crucial mediators of the anti-inflammatory properties of mesenchymal stem/stromal cells.
- Understanding these miRNA-mediated mechanisms can advance the development of novel cell-based and cell-free therapies for inflammatory diseases.
- Further research into MSC-derived miRNAs holds significant promise for regenerative medicine and immunotherapy.
Related Concept Videos
Mesenchymal Stem Cells
MicroRNAs
MicroRNAs
Adult Stem Cells
Embryonic Stem Cells
Binet's Contribution to Measures of Intelligence

